Radical prostatectomy in high-risk prostate cancer - Wikidata - wikimedia - TriplyDB

Radical prostatectomy in high-risk prostate cancer

Radical prostatectomy in high-risk prostate cancer

http://www.wikidata.org/entity/Q57131976

about

A Randomized Control Trial Comparing the Efficacy of Antiandrogen Monotherapy: Flutamide vs. Bicalutamide Inhibition of androgen receptor promotes CXC-chemokine receptor 7-mediated prostate cancer cell survival.Current status of radical prostatectomy for high-risk prostate cancer.Role of robot-assisted radical prostatectomy in the management of high-risk prostate cancer Oncologic Outcome of Radical Prostatectomy as Monotherapy for Men with High-risk Prostate Cancer.The status of surgery in the management of high-risk prostate cancer.Is Radical Perineal Prostatectomy a Viable Therapeutic Option for Intermediate- and High-risk Prostate Cancer?Efficacy of Bicalutamide 150-mg Monotherapy Compared With Combined Androgen Blockade in Patients With Locally Advanced Prostate Cancer.Matched comparison of outcomes following open and minimally invasive radical prostatectomy for high-risk patients.Biodistribution and Efficacy of Low Temperature-Sensitive Liposome Encapsulated Docetaxel Combined with Mild Hyperthermia in a Mouse Model of Prostate Cancer.Editorial Comment from Dr Miyata and Dr Sakai to Sulfoquinovosylacylpropanediol is a novel potent radiosensitizer in prostate cancer.Prostate stem cell antigen mRNA in blood is a predictor of survival after radical prostatectomy in patients with high-risk prostate cancer.

P2860

Q28262606-643E2722-0535-4E08-9045-6136274C595F Q33780482-C82202F3-4A40-4F1F-96C8-509F872875CA Q34346841-956DADA4-7404-4A60-8252-BEE9533DA0BF Q34453371-1B320EFA-6CF9-42FC-BED6-0DE2A5D6254F Q37014814-002CB33E-6860-4BCB-9C63-EEA123FFCD22 Q38211115-4123A69B-C4F5-4486-8040-7930EA8687A3 Q38946078-95DE1F85-4E45-423B-B9BF-14D9AF6DB215 Q39756960-993D6904-8E74-4365-B82D-BDC2F6C47C2D Q42647426-508875B3-FEF9-42C9-B00F-1C3F9EABD13B Q50883487-D323FD24-4A70-4F78-9996-03884593FAC0 Q53532263-ED375F43-1CC1-423A-9882-90DD54D21D0D Q55188158-4A99C548-BFCD-416D-9A91-D87C51655794

P2860

Radical prostatectomy in high-risk prostate cancer

http://www.wikidata.org/entity/Q57131976

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в березні 2013

@uk

name

Radical prostatectomy in high-risk prostate cancer

@en

Radical prostatectomy in high-risk prostate cancer

@nl

type

label

Radical prostatectomy in high-risk prostate cancer

@en

Radical prostatectomy in high-risk prostate cancer

@nl

prefLabel

Radical prostatectomy in high-risk prostate cancer

@en

Radical prostatectomy in high-risk prostate cancer

@nl

P1433

Q57131976-FA884A4D-78E3-49FA-8F23-6620B8F88656

P1476

Q57131976-E8C59DE9-EC76-45B8-9F5B-A495C04434AE

P2093

Q57131976-1536A046-A083-4DDC-8E2D-BD9318F10EBC

Q57131976-EBB39533-BB2F-4375-A786-260AF5F68579

P2860

Q57131976-04D2D06A-5D0F-40A8-89C5-E7B40AB211EF

Q57131976-06C3A81E-F554-4350-8682-068EAA41203A

Q57131976-07A1FFEC-632E-4644-A2B8-D1BA2C884C1D

Q57131976-07DDD641-08BA-48AA-9582-44BBAA8CF9EC

Q57131976-08636173-F632-4F3F-A745-8E8D751BB5DE

Q57131976-08C87D8F-F31F-41D2-8F4E-DF12E6A4CFCE

Q57131976-09339B1F-0A34-43C7-AE37-C82BFA2AD1AF

Q57131976-0A8D3145-ADC8-4B2A-B531-37A5E876BC88

Q57131976-0E76541E-DAA1-42F5-8BBA-653955757C78

Q57131976-10E24A28-795E-4D52-BD94-09AF30628065

P304

Q57131976-2CB4D42C-32F6-4A7B-A678-FDC383EB78D7

P31

Q57131976-FF5AD7AA-5EA6-4BC4-AFFD-003B69651745

Q57131976-ad1e20be-eab2-40a7-b3cd-1436523c51c4

P356

Q57131976-97CAD7E9-E6E7-4D7C-A6F5-6E00CF5357FF

P407

Q57131976-EBF5D7D7-87E2-47DB-AB1B-488F116CE521

P433

Q57131976-EE425FA6-3816-4082-9D72-B46F30FBFE7C

P478

Q57131976-B672B362-7BDD-47DF-B885-67B698920AA4

P577

Q57131976-DCAE41C9-C614-4C15-B5DC-8976B4FB23DD

P698

Q57131976-3248ADE6-03E5-4597-96EF-61C6277315DF

P356

P1433

International Journal of Urology

P1476

Radical prostatectomy in high-risk prostate cancer

@en

P2093

Joseph Ischia

http://www.w3.org/2001/XMLSchema#string

Martin Gleave

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

Case-matched comparison of contemporary radiation therapy to surgery in patients with locally advanced prostate cancer.

Time trends in clinical risk stratification for prostate cancer: implications for outcomes (data from CaPSURE).

A systematic review and meta-analysis of randomised trials of neo-adjuvant hormone therapy for localised and locally advanced prostate carcinoma.

Time trends and local variation in primary treatment of localized prostate cancer

What are the outcomes of radical prostatectomy for high-risk prostate cancer?

Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era: a large single-institution experience with radical prostatectomy and external-beam radiotherapy.

High-risk prostate cancer in the United States, 1990-2007

P304

290-300

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/IJU.12069

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23305529

http://www.w3.org/2001/XMLSchema#string